Filters

GLP-1 Antibody

GLP-1 Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameGLP-1 Primary Polyclonal Antibody
Also known asGLP-1 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenGLP-1
SpecificityThis is a highly specific antibody against GLP-1
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Subcellular locationSecreted
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human GLP-1
Gene ID number2641
Swiss ProtP01275
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen A counterregulatory hormone of insulin, CRH, GLP-1 is a potent stimulator of glucose-dependent insulin release, GLP-2 stimulates intestinal growth and up-regulates villus height in the small intestine, Glicentin may modulate gastric acid secretion and the gastro-pyloro-duodenal activity, Have growth-promoting activities on intestinal epithelium, Increases islet mass through stimulation of islet neogenesis and pancreatic beta cell proliferation, Inhibits beta cell apoptosis, Inhibits gastric emptying in humans, May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, May be involved in the suppression of satiety and stimulation of glucose disposal in peripheral tissues, May play an important role in intestinal mucosal growth in the early period of life, Oxyntomodulin significantly reduces food intake, Play important roles on gastric motility and the suppression of plasma glucagon levels, Plays a key role in nutrient homeostasis, Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes, Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis, Stimulates intestinal glucose transport and decreases mucosal permeability, Suppression of gastric emptying may lead to increased gastric distension, TSH, The gastrointestinal tract, and vasopressin secretion, as well as increasing nutrient disposal, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis, enhancing nutrient assimilation through enhanced gastrointestinal function, from the stomach to the colon is the principal target for GLP-2 action, independent of the actions of insulin, oxytocin, raises plasma glucose levels in response to insulin-induced hypoglycemia, which may contribute to satiety by causing a sensation of fullness, Glucagon plays a key role in glucose metabolism and homeostasis
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names GCG, GLP2, GRPP, Glucagon, GLP1
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetGLP-1
Short nameGLP-1 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameGLP-1 (Antibody to)
Alternative techniqueantibodies
Identity 37245
Gene ZGLP1
Long gene name GATA-like protein 1 , zinc finger
Synonyms GLP1 GLP-1 GATAD3
Synonyms name GATA like protein 1 GATA zinc finger domain containing 3
Locus 19p13, 2
Discovery year 2009-10-02
GenBank acession AK096830
Entrez gene record 100125288
Pubmed identfication 16982049
RefSeq identity NM_001103167
Classification GATA zinc finger domain containing
Havana BLAST/BLAT OTTHUMG00000152114

Subscribe to our Newsletter